Unknown

Dataset Information

0

The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties.


ABSTRACT: IL-17A and IL-17F are prominent members of the IL-17 family of cytokines that regulates both innate and adaptive immunity. IL-17A has been implicated in chronic inflammatory and autoimmune diseases, and anti-IL-17A antibodies have shown remarkable clinical efficacy in psoriasis and psoriatic arthritis patients. IL-17A and IL-17F are homodimeric cytokines that can also form the IL-17A/F heterodimer whose precise role in health and disease remains elusive. All three cytokines signal through the assembly of a ternary complex with the IL-17RA and IL-17RC receptors. Here we report the X-ray analysis of the human IL-17A/F heterodimer that reveals a two-faced cytokine closely mimicking IL-17A as well as IL-17F. We also present the crystal structure of its complex with the IL-17RA receptor. Unexpectedly in view of the much higher affinity of this receptor toward IL-17A, we find that IL-17RA is bound to the "F-face" of the heterodimer in the crystal. Using site-directed mutagenesis, we then demonstrate that IL-17RA can also bind to the "A-face" of IL-17A/F with similar affinity. Further, we show that IL-17RC does not discriminate between the two faces of the cytokine heterodimer either, thus enabling the formation of two topologically-distinct heterotrimeric complexes with potentially different signaling properties.

SUBMITTER: Goepfert A 

PROVIDER: S-EPMC5566378 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties.

Goepfert Arnaud A   Lehmann Sylvie S   Wirth Emmanuelle E   Rondeau Jean-Michel JM  

Scientific reports 20170821 1


IL-17A and IL-17F are prominent members of the IL-17 family of cytokines that regulates both innate and adaptive immunity. IL-17A has been implicated in chronic inflammatory and autoimmune diseases, and anti-IL-17A antibodies have shown remarkable clinical efficacy in psoriasis and psoriatic arthritis patients. IL-17A and IL-17F are homodimeric cytokines that can also form the IL-17A/F heterodimer whose precise role in health and disease remains elusive. All three cytokines signal through the as  ...[more]

Similar Datasets

| S-EPMC6274717 | biostudies-literature
| S-EPMC5641557 | biostudies-literature
| S-EPMC7105470 | biostudies-literature
| S-EPMC3536140 | biostudies-literature
| S-EPMC4580732 | biostudies-other
| S-EPMC2965829 | biostudies-literature
| S-EPMC3916096 | biostudies-literature
| S-EPMC7362799 | biostudies-literature
| S-EPMC9147816 | biostudies-literature
| S-EPMC5234565 | biostudies-literature